Overactive Bladder Changes with Time: A 5-Year Longitudinal Followup of Changes in Overactive Bladder Symptoms, Urodynamic Studies and Urinary Nerve Growth Factor Levels-Reference-Cited by-同舟云学术

Overactive Bladder Changes with Time: A 5-Year Longitudinal Followup of Changes in Overactive Bladder Symptoms, Urodynamic Studies and Urinary Nerve Growth Factor Levels

Published:2014-08 Issue:2 Volume:192 Page:458-463
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Chuang Fei-Chi¹,Liu Hsin-Tzu²³,Wang Li-Yu⁴,Kuo Hann-Chorng²⁵

Affiliation:

1. Department of Obstetrics and Gynecology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan, Republic of China

2. Department of Urology, Buddhist Tzu Chi General Hospital, Hualien, Taiwan, Republic of China

3. Institute of Pharmacology and Toxicology, Tzu Chi University, Hualien, Taiwan, Republic of China

4. Department of Medicine, Mackay Medical College, New Taipei City, Taiwan, Republic of China

5. Department of Urology, Tzu Chi University, Hualien, Taiwan, Republic of China

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference27 articles.

1. Urinary urgency: a review of its assessment as the key symptom of the overactive bladder syndrome;Abrams;World J Urol,2012

2. Pathophysiology of overactive bladder and urge urinary incontinence;Steers;Rev Urol,2002

3. Defining overactive bladder as hypersensitivity;Yamaguchi;Neurourol Urodyn,2007

4. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction;Haylen;Neurourol Urodyn,2010

5. Urinary nerve growth factor level could be a potential biomarker for diagnosis of overactive bladder;Liu;J Urol,2008

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platelet-rich plasma attenuates the UPEC-induced cystitis via inhibiting MMP-2,9 activities and downregulation of NGF and VEGF in Canis Lupus Familiaris model;Scientific Reports;2024-06-13

2. Current optimal pharmacologic therapies for overactive bladder;Expert Opinion on Pharmacotherapy;2023-10-05

3. Retrospective Observational Study of Treatment Patterns and Efficacy of onabotulinumtoxinA Therapy in Patients with Refractory Overactive Bladder in Clinical Practice;Toxins;2023-05-15

4. Recurrent urinary tract infection in women and overactive bladder – Is there a relationship?;Tzu Chi Medical Journal;2021

5. Partners in Crime: NGF and BDNF in Visceral Dysfunction;Current Neuropharmacology;2019-10-02